Press Releases for SQNM

Press Releases
Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
SEQUENOM Announces August 6 Webcast of Financial and Other Business Results
SEQUENOM Announces Launch of MassARRAY Compact 96 System
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
Pomerantz Reminds Sequenom, Inc. Investors of Tuesday, June 30 Deadline
Kendall Law Group, Led By a Former Federal Judge and U.S. Attorney, Reminds Investors About the Upcoming Lead Plaintiff Deadline in the Sequenom Case
Ann D. White Law Offices, P.C. Announces That a Securities Class Action Lawsuit Has Been Filed Against Sequenom, Inc.
Pomerantz Reminds Sequenom, Inc. Investors of June 30 Deadline -- SQNM
INVESTOR ALERT: Former Attorney General of Louisiana Charles C. Foti, Jr. and KSF Notify Sequenom, Inc. Investors of Lead Plaintiff Application Deadline in Securities Fraud Class Action Lawsuit -- SQNM
Holzer Holzer & Fistel, LLC Announces It Has Filed a Shareholder Class Action Against Sequenom, Inc. (NASDAQ: SQNM)
The Pomerantz Firm Reminds Investors of Sequenom, Inc. of Lead Plaintiff Deadline -- SQNM
Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Sequenom, Inc. - May 19 2009 1:20PM
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Sequenom, Inc. (NASDAQ: SQNM)
Dyer & Berens LLP Files Class Action Lawsuit on Behalf of Investors Who Purchased Sequenom, Inc. Common Stock Between June 4, 2008 and April 29, 2009; Announces Upcoming Investor Deadline -- SQNM
Scott+Scott LLP Files Class Action Lawsuit Against Sequenom, Inc. On Behalf of Investors -- SQNM
Brower Piven Encourages Investors Who Have Losses in Excess of $200,000 From Investment in Sequenom, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the June 30, 2009 Lead Plaintiff Deadline
Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Spector, Roseman Kodroff & Willis, P.C. Announces the Filing of a Class Action Suit Against Sequenom, Incorporated
The Pomerantz Firm Charges Sequenom, Inc. With Securities Fraud -- SQNM
Saxena White P.A. Has Filed a Securities Fraud Class Action Against Sequenom, Inc.
Stanley Mandel & Iola and the Braun Law Group Announce the Filing of a Class Action Lawsuit Against Sequenom, Inc.
Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Sequenom, Inc. - May 6 2009 5:23PM
Charles H. Johnson & Associates Announces Filing of Securities Class Action Against Sequenom, Inc.
INVESTOR NOTICE: The Rosen Law Firm Announces Filing of Securities Class Action Against Sequenom, Inc. -- SQNM
Abbey Spanier Rodd & Abrams, LLP, Announces Class Action Lawsuit on Behalf of Sequenom, Incorporated Shareholders
SEQUENOM Reports First Quarter 2009 Financial Results
SEQUENOM Announces Cost Cutting Initiative in Genetic Analysis Business
Sequenom to Present at Two Investment Community Conferences in March
Sequenom Adopts Share Purchase Rights Plan - Mar 4 2009 7:14AM
Sequenom Selects PDI to Provide Sales Team for Launch of Noninvasive Prenatal Screening Tests
High-Throughput Genotyping of AML Patients for a Key Immune Receptor May Significantly Improve Treatment Outcome
Sequenom Reports Fourth Quarter Financial Results
Sequenom to Hold Fourth Quarter and Full Year 2008 Financial Results Conference Call on February 11
Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM
Sequenom Announces New Positive Data on Down Syndrome Detection and Unveils Breakthrough DNA Approach to Prenatal Diagnostics
Sequenom Center for Molecular Medicine Collaborates with Obstetrix Medical Group to Provide Clinical Samples for LDT Validation Study
Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics - Jan 28 2009 9:43AM
Sequenom Terminates Exchange Offer to Acquire EXACT Sciences
Sequenom Commences Exchange Offer to Acquire EXACT Sciences
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer
Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics - Jan 21 2009 1:43PM
Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics - Jan 20 2009 8:09PM
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
BenchmarkJournal.Com (Complimentary) Analyst Review for SQNM, NVDA, AMAT and ADBE
Sequenom to Commence Exchange Offer to Acquire EXACT Sciences
The Immune Tolerance Institute, Sequenom and the University of California, San Francisco to Develop Advanced Diagnostic Test for Severe Combined Immunodeficiency in Newborns
Sequenom Proposes to Acquire EXACT Sciences for $1.50 Per Share or Approximately $41 Million
Sequenom to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 15
Next-Generation Noninvasive Diagnostic Technology Shown to Accurately Detect Fetal Down Syndrome in First Trimester of Pregnancy
New Noninvasive Prenatal Diagnostic Technology Allows Diagnosis of Inherited Diseases Such as Cystic Fibrosis Caused by Single Gene Mutations
Sequenom Completes Acquisition of CLIA-Certified Laboratory
Sequenom Reports 2008 Third Quarter Financial Results
Xenomics Announces License Agreement with Sequenom for Prenatal Diagnostic Applications of Transrenal Nucleic Acid Technology
Sequenom Announces Exclusive Licensing Agreement with Xenomics for Noninvasive Prenatal Diagnostics Using Transrenal DNA
Sequenom Announces Launch of RNA-Based Noninvasive Aneuploidy (RNA) Study
Sequenom to Hold 2008 Third Quarter Financial Results Conference Call on October 30
Sequenom Announces Additional, Positive Results for Down Syndrome Test at Analyst Briefing
Sequenom Announces Acquisition of CLIA-Certified Laboratory and Partnerships with Spectrum Health and Van Andel Research Institute
Sequenom to Webcast Analyst and Investor Briefing Presentation on September 23
Sequenom Announces Exclusive Licensing Agreement with Genomic Nanosystems for Digital PCR Technologies and Methods Patents
Sequenom Acquires Exclusive License to Digital PCR and Other Noninvasive Prenatal Diagnostic Intellectual Property
Sequenom to Present at September Investment Conferences and to Hold Analyst and Investor Briefing Event
Sequenom Certifies McGill University and Genome Quebec Innovation Centre as First Center of Excellence
Sequenom to Present at Leerink Swann Emerging Products and Applications in Life Science Tools Conference
Sequenom Reports 2008 Second Quarter Financial Results
Sequenom and SensiGen Expand Global Alliance
Sequenom to Hold 2008 Second Quarter Financial Results Conference Call on July 30
Sequenom Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares
Sequenom Launches iSEQ Application
Sequenom Announces Pricing of Public Offering of Common Stock
Sequenom Launches Public Offering of Common Stock
Sequenom to Present at 7th Annual Needham & Company Biotechnology & Medical Technology Conference
OHSU Cancer Institute to Use Sequenom's MassARRAY Technology for Cancer Research
BellwetherReport.com Analyst Report on IDEV, TIBX, SQNM and PMCS
Sequenom Announces Results of Screening Studies for Down Syndrome and Updates Development of Noninvasive Prenatal Diagnostics at Analyst and Investor Briefing
Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
Johns Hopkins University Purchases Sequenom MassARRAY Platform
Sequenom to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference - Jun 2 2008 4:37AM
Yale University Purchases Sequenom MassARRAY Platform - Jun 2 2008 4:37AM
Sequenom Abstract Selected for 'Blue Ribbon' Designation for Presentation at ACOG Annual Meeting - Jun 2 2008 4:37AM
Sequenom Reports 2008 First Quarter Financial Results
Sequenom Announces Distribution Agreement with Invitrogen for South and Central America; Sells First MassARRAY System in Brazil
Sequenom to Hold 2008 First Quarter Financial Results Conference Call on April 30
BellwetherReport.com Free Analyst Review for LDK, STZ, SQNM and PLXS
Sequenom Updates 2008 Financial Guidance